Active — Not RecruitingNot Applicable

Cost-Effectiveness of Retromuscular Hernia Repair

Spain120 participantsStarted 2026-01-01

Plain-language summary

This prospective observational study aims to evaluate the clinical outcomes and cost-effectiveness of retromuscular midline ventral hernia repair using open, laparoscopic and robotic approaches. Patients undergoing elective repair are included and followed to assess postoperative complications, length of hospital stay, recurrence and quality of life. In addition, a cost-effectiveness analysis will be performed from the perspective of the Spanish National Health System. The study is currently ongoing.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults ≥ 18 years * Patients scheduled for elective retromuscular repair of midline ventral hernia * Primary hernia or recurrent hernia without previous retromuscular repair * Hernia defect width between 5 and 12 cm (EHS W2-W3) * Ability to understand the study and provide informed consent Exclusion Criteria: * Contraindication to general anesthesia * Contraindication to minimally invasive or open surgery * Body mass index (BMI) \> 35 kg/m² * ASA physical status \> IV * Previous retromuscular hernia repair * Lateral or parastomal hernias * Emergency surgery * Advanced disease with life expectancy \< 2 years * Pregnancy or planned pregnancy during follow-up * Conditions significantly affecting wound healing or surgical risk (e.g., severe immunosuppression, active chemotherapy, connective tissue disorders)

What they're measuring

Length of hospital stay

Timeframe: From date of surgery until hospital discharge (typically within 30 days postoperative)

Trial details

NCT IDNCT07530159

SponsorFátima Hinojosa Ramírez

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-01-01